Onco-Innovations Limited (NEO:ONCO)
Canada · Delayed Price · Currency is CAD 0.2800
-0.0400 (-12.50%)
Oct 19, 2026, 1:24 PM EST
Onco-Innovations Market Cap
Onco-Innovations has a market cap or net worth of CAD 19.38 million as of October 19, 2026. It is the 38,751st most valuable company in the world and the 1,280th biggest in Canada. Its market cap has decreased by 74.54% in one year.
Market Cap
19.38M
Enterprise Value
19.55M
Revenue
90.88K
Global Rank
Country Rank
#1,280 Canada
PE Ratio
n/a
ChartMarket Cap Chart
Since November 27, 2024, Onco-Innovations's market cap has decreased from 28.39M to 19.38M, a decrease of -31.72%. That is a compound annual growth rate of -18.26%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 19, 2026 | 19.38M | -74.44% |
| Dec 30, 2025 | 75.84M | 115.86% |
| Dec 31, 2024 | 35.13M | 23.76% |
| Nov 27, 2024 | 28.39M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Thiogenesis Therapeutics | 34.99M |
| Telescope Innovations | 32.33M |
| Resverlogix | 27.54M |
| Defence Therapeutics | 25.77M |
| The More Life Company | 22.85M |
| Devonian Health Group | 19.74M |
| Pharmala Biotech Holdings | 17.00M |
| Lobe Sciences | 16.98M |